64 related articles for article (PubMed ID: 29630110)
1. Overexpression of UBE2C correlates with poor prognosis in gastric cancer patients.
Zhang HQ; Zhao G; Ke B; Ma G; Liu GL; Liang H; Liu LR; Hao XS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1665-1671. PubMed ID: 29630110
[TBL] [Abstract][Full Text] [Related]
2. Role of UBE2C in Brain Cancer Invasion and Dissemination.
Domentean S; Paisana E; Cascão R; Faria CC
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958776
[TBL] [Abstract][Full Text] [Related]
3. Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer.
Martínez-Canales S; López de Rodas M; Nuncia-Cantarero M; Páez R; Amir E; Győrffy B; Pandiella A; Galán-Moya EM; Ocaña A
Cancer Med; 2018 May; 7(5):1896-1907. PubMed ID: 29575713
[TBL] [Abstract][Full Text] [Related]
4. UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.
Jalali P; Samii A; Rezaee M; Shahmoradi A; Pashizeh F; Salehi Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2032. PubMed ID: 38577722
[TBL] [Abstract][Full Text] [Related]
5. Identification of small molecule inhibitors against UBE2C by using docking studies.
Sabitha K; Rajkumar T
Bioinformation; 2012; 8(21):1047-58. PubMed ID: 23275705
[TBL] [Abstract][Full Text] [Related]
6. UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability.
Zhang J; Liu X; Yu G; Liu L; Wang J; Chen X; Bian Y; Ji Y; Zhou X; Chen Y; Ji J; Xiang Z; Guo L; Fang J; Sun Y; Cao H; Zhu Z; Yu Y
Front Pharmacol; 2018; 9():847. PubMed ID: 30116193
[TBL] [Abstract][Full Text] [Related]
7.
Liu Y; Zhao R; Chi S; Zhang W; Xiao C; Zhou X; Zhao Y; Wang H
Mol Cancer Res; 2020 Feb; 18(2):204-215. PubMed ID: 31662448
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Bioinformatics Analysis of
Dastsooz H; Cereda M; Donna D; Oliviero S
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067633
[TBL] [Abstract][Full Text] [Related]
9. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
10. UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR.
Chiang AJ; Li CJ; Tsui KH; Chang C; Chang YI; Chen LW; Chang TH; Sheu JJ
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396624
[TBL] [Abstract][Full Text] [Related]
11. USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction.
Kim MJ; Min Y; Jeong SK; Son J; Kim JY; Lee JS; Kim DH; Lee JS; Chun E; Lee KY
Cell Death Dis; 2022 Apr; 13(4):348. PubMed ID: 35422093
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma.
Xiang C; Yan HC
Cell Death Discov; 2022 Mar; 8(1):130. PubMed ID: 35332135
[TBL] [Abstract][Full Text] [Related]
13. UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma.
Liu PF; Chen CF; Shu CW; Chang HM; Lee CH; Liou HH; Ger LP; Chen CL; Kang BH
Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32899896
[TBL] [Abstract][Full Text] [Related]
14. UBE2C overexpression in melanoma and its essential role in G2/M transition.
Liu G; Zhao J; Pan B; Ma G; Liu L
J Cancer; 2019; 10(10):2176-2184. PubMed ID: 31258721
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma.
Ong KH; Lai HY; Sun DP; Chen TJ; Huang SK; Tian YF; Chou CL; Shiue YL; Chan TC; Li CF; Kuo YH
Eur J Med Res; 2023 Dec; 28(1):593. PubMed ID: 38102624
[TBL] [Abstract][Full Text] [Related]
16. UBE2C promotes malignancy of cutaneous squamous cell carcinoma.
Luo R; Bai R; Guo J; Xian N; Zheng Y
Skin Res Technol; 2023 Nov; 29(11):e13526. PubMed ID: 38009019
[TBL] [Abstract][Full Text] [Related]
17. Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency.
Liu D; Guan X; Liu W; Jia Y; Zhou H; Xi C; Zhao M; Fang Y; Wu L; Li K
J Ovarian Res; 2023 Oct; 16(1):203. PubMed ID: 37848988
[TBL] [Abstract][Full Text] [Related]
18. Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance.
Long J; Zhu B; Tian T; Ren L; Tao Y; Zhu H; Li D; Xu Y
Open Med (Wars); 2023; 18(1):20230757. PubMed ID: 37840753
[TBL] [Abstract][Full Text] [Related]
19. System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma.
Huang R; Guo L; Chen C; Xiang Y; Li G; Zheng J; Wu Y; Yuan X; Zhou J; Gao W; Xiang S
PLoS One; 2023; 18(8):e0289418. PubMed ID: 37535572
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
